Innocoll Announces Successful Completion Of Debt Refinancing
$125 million refinancing substantially improves Innocoll’s liquidity, enabling further investment in pharmaceutical technology portfolio and growth plan Innocoll Biotherapeutics plc, a specialty pharmaceutical company and portfolio business of Gurnet Point Capital, announced the successful refinancing of its existing term loan facility with a new $125 million term loan provided by......